Healthy volunteers to test high doses of flu drug favipiravir
NCT ID NCT06024421
First seen Feb 20, 2026 · Last updated May 12, 2026 · Updated 7 times
Summary
This study tests the safety of high doses of favipiravir, an antiviral drug, in 39 healthy volunteers. Participants receive different dose levels for 14 days to see how well the body handles the drug and how it is processed. The goal is to gather safety and drug-level information, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFECTIOUS DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital Bichat - Claude Bernard
RECRUITINGParis, 75018, France
Contact
Contact
Conditions
Explore the condition pages connected to this study.